Baricitinib para lupus
Baricitinib Succeeds As Treatment For Lupus In Mid-Stage Trial.
Reuters (6/13, Mathias) reports Eli Lilly & Co said baricitinib successfully treated lupus and met the main goal of a mid-stage trial. In the trial, "67 percent of patients on a 4 mg dose of baricitinib showed a resolution of arthritis or rash, common symptoms of lupus, compared with 53 percent on a placebo" after 24 weeks. The findings were presented at the Annual European Congress of Rheumatology.
Sent from my iPad
Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 2224-0654
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home